Related Experiment Video
Updated: Aug 15, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 31, 2013
Urinary beta-glucuronidase in screening and followup of primary urinary tract malignancy
1Department of Laboratory Medicine, National Taiwan University, College of Medicine, Taipei.
Purpose:
The usefulness of urinary beta-glucuronidase in screening and followup of urinary tract malignancy was tested.
Materials And Methods:
The activity and concentration of urinary beta-glucuronidase were determined in 80 healthy subjects, 113 urology patients with no cancer, and 60 with transitional cell and 23 with renal cell carcinoma. Patients with cancer were followed for 3 to 33 weeks.
Results:
The enzyme activity and concentration were significantly greater in the cancer group, including residual tumor or recurrence after therapy, than in the controls with excellent discrimination.
Conclusions:
Urinary beta-glucuronidase was indeed useful in screening and followup of urinary tract malignancy.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies I: Urinalysis
Imaging Studies II: Ultrasonography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urine Studies II: Urine Culture and Sensitivity Test

